GB2271719A - Germicidal composition and soap - Google Patents
Germicidal composition and soap Download PDFInfo
- Publication number
- GB2271719A GB2271719A GB9321537A GB9321537A GB2271719A GB 2271719 A GB2271719 A GB 2271719A GB 9321537 A GB9321537 A GB 9321537A GB 9321537 A GB9321537 A GB 9321537A GB 2271719 A GB2271719 A GB 2271719A
- Authority
- GB
- United Kingdom
- Prior art keywords
- soap
- germicidal
- microorganisms
- composition
- germicidal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002070 germicidal effect Effects 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 239000000344 soap Substances 0.000 title claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims 1
- QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 57
- 230000001954 sterilising effect Effects 0.000 abstract description 19
- 241001465754 Metazoa Species 0.000 abstract description 7
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 abstract description 4
- HFOCAQPWSXBFFN-UHFFFAOYSA-N 2-methylsulfonylbenzaldehyde Chemical compound CS(=O)(=O)C1=CC=CC=C1C=O HFOCAQPWSXBFFN-UHFFFAOYSA-N 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 abstract description 3
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 abstract description 2
- WDRFFJWBUDTUCA-UHFFFAOYSA-N chlorhexidine acetate Chemical compound CC(O)=O.CC(O)=O.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WDRFFJWBUDTUCA-UHFFFAOYSA-N 0.000 abstract description 2
- 238000011109 contamination Methods 0.000 abstract description 2
- 230000002458 infectious effect Effects 0.000 abstract description 2
- 244000000010 microbial pathogen Species 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 229960001884 chlorhexidine diacetate Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 16
- 241000233866 Fungi Species 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000009422 growth inhibiting effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 239000000470 constituent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 239000008149 soap solution Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000228257 Aspergillus sp. Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 241000591119 Trichophyton sp. Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940023064 escherichia coli Drugs 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241001149959 Fusarium sp. Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000228153 Penicillium citrinum Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000519996 Teucrium chamaedrys Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001420 bacteriolytic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000011363 dried mixture Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/10—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0047—Detergents in the form of bars or tablets
- C11D17/006—Detergents in the form of bars or tablets containing mainly surfactants, but no builders, e.g. syndet bar
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Abstract
A germicidal composition comprises diiodomethyl-p-tolyl sulfone (I), and 5-amino-1,3-bis(2-ethylhexyl)-5-methyl-hexahydropyrimidine (II) and/or a salt III selected from the group consisting of chlorhexidine diacetate, chlorhexidine digluconate or chlorhexidine dihydrochloride in a suitable organic solvent. A germicidal soap containing the compound I and at least one or both of the compounds II and III is also disclosed. The germicidal composition and soap are capable of preventing the contamination of daily goods and protecting human bodies from infectious or pathogenic microorganisms, and are also effective in the sterilization and treatment of an infected part. The composition is effective for various groups of microorganisms (including eucaryotic cells and procaryotic cells) and is safe to human bodies, animals and plants. <IMAGE>
Description
GERMICIDAL COMPOSITION AND SOAP CONTAINING THE SAME
BACKGROUND OF THE INVENTION
Field of the invention
The present invention relates in general to a germicidal composition and a soap containing the same, and more particularly to a composition having a variety of sterilizing spectra, harmless to human body and a soap containing the same, capable of inhibiting the growth of microorganisms which are parasitic on the skin to cause a variety of cutaneous diseases and sterilizing the parasites.
Description of the Prior Art
Microorganisms, by definition, are called organisms that are too small to be perceived clearly by the unaided human eye. They are able to grow and reproduce for themselves under suitable conditions such as nutrients, humidity, temperature and the like. Microorganisms have a wide taxonomic distribution; they include some metazoan animals, protozoa, many algae and fungi, bacteria, and viruses.
Such microorganisms always exist all around, for example, in the human skin and even where the magma erupts. They play important roles in circulating matters in the ecosystem. In addition, they are utilized in industrially important processes, such as the production of critical medicines, foods and the like. However, some microorganisms may infect humans, animals or plants to cause a variety of diseases therein.
Other microorganisms may putrefy lumber, paper, cloth, food, etc., so that the quality of life environment is deteriorated.
On human skin, microorganisms inhabit in the quantity of approximately 104 colony forming units (hereinafter "cfu") per 1 cm2 of the skin. This group of microorganisms is called a normal flora, which is harmless to the human body. Rather, it is advantageous, since it prevents the skin from being infected by other harmful microorganisms. The number of normal flora is maintained constant by the correlation of the bacteriolytic properties of hydrolytic enzymes (e.g.
lysozymes) which are widespread in biological tissues and secretions, the transferin which is also a kind of secretions, and the metabolites of the microorganisms themselves.
However, if a human body comes to be weak in his or her immune system or comes in contact with a contaminated substance, particular pathogenic microorganisms propagate abnormally, so that he or she becomes ill with bacterial or fungal diseases.
The lumber, cloth, paper, food and etc., which are founded easily in daily life, may provide ideal inhabitats to microorganisms and thence are often contaminated with them.
Moreover, in extreme condition such as nutrient limitation, high temperature, dry condition and the like, microorganisms can produce microscopically distinguishable resting bodies (endospores) which are highly resistant to heat and dry condition, so that they survive until the extreme environment is improved. Accordingly, there always exists a possibility such that human body is infected with the microorganisms through contaminated floor, cloth, wallpaper, dish towel or food.
It is known that a substantial part of infected skin diseases (in USA, 5 to 10 % of total hospital patients) are acquired through a public health institute such as a hospital (hospital-acquired infection). It is believed that the diseases propagate among patients, utilizing the medical personnels and instruments which are always in contact with the patients as carriers. Furthermore, the patient who becomes to have a weakened immune function caused by administration of drugs or surgery and thus is badly resistant to the infection develops to a very serious state.
In an effort to solve the problems, a germicidal cleanser of a form of an ointment or a soap is suggested in Korean
Patent Publication No. 90-2935. However, the cleanser's sterilizing ability is doubtful. In addition, until now, there has not been developed a germicidal material which is utilized easily at any time, regardless of place.
According to the requirement, it is necessary to develop a germicidal composition, which is capable of the preventing contamination of daily goods and protecting human bodies from being infected with the infectious microorganisms, and which is further effective in sterilization and treatment for an infected part and is safe to human bodies, animals and plants.
In developing a germicidal substance, difficulties encountered are the diversity of microorganisms and the safety to human body.
There is recognized a profoundly important dichotomy among the various groups of microorganisms with respect to the internal architecture of the cell. Two radically different kinds of cells exist in the contemporary living world. The more complex eucaryotic cell is the unit of structure in metazoan animals, protozoa, fungi, and all save one of the groups that had traditionally been assigned to the algae. The less complex procaryotic cell is the unit of structure in two microbial groups; the eubacteria and the archaebacteria. Of the procaryotes, the eubacteria can be subdivided into Gramnegative eubacteria and Gram-positive eubacteria on the basis of the structure of the cell wall. In general, microorganisms diversely response to germicidal substances. A germicidal substance is often ineffective to the Gram-negative bacteria even though it kills the Gram-positive bacteria.Moreover, it is common that a substance with a potent sterilizing power for both the Gram-positive and Gram-negative bacteria is incapacitated for the eucaryotic microorganisms such as yeasts and fungi.
SUMMARY OF THE INVENTION
For solving the aforementioned problems, the inventors have recognized that there exists a need for a germicidal composition, effective for a wide extent of microorganisms, which is capable of inhibiting the growth of microorganisms or sterilizing them and is safe to human bodies, animals and plants, and for an easily usable form of a material including the germicidal composition at any time, regardless of place.
Accordingly, in an aspect of the present invention, there is provided a germicidal composition which is capable of sterilizing microorganisms over various groups.
According to another aspect of the present invention, there is provided a germicidal composition which is safe to human body and other living bodies such as animals and plants.
According to a further aspect of the present invention, there is provided a soap which has an excellent inhibitory effect and disinfecting power for microorganisms.
The above objects are accomplished by providing a composition which comprise a compound represented by the following formula I;
at least one or both of compounds represented by the following formulas II and III
wherein R is selected from the group consisting of diacetate, digluconate and dihydrochloride; and a solvent.
The compounds of the above formulas I, II and III are known to be harmless to human body.
These and other objects together with others not sDecifically mentioned will become clear to those skilled in the art as the following description proceeds.
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter. the present invention will be described in detail.
Used as an ingredient of the inventive germicidal composition, diiodomethyl-p-tolyl sulfone represented by the formula I has a potent germicidal power for Gram-Dositive bacteria, yeasts and fungi, but is little effective to Gramnegative. Another potent ingredient represented by the formula II, 5-amino-1,3-bis(2-ethylhexyl)-5-methylhexahydropyrimidine is capacitated to disinfect Gram-negative bacteria. The other compound represented by the formula III, which is selected from chlorhexidine (1,1'-hexamethylene- bis[5-(4-chlorophenyl)biguanide]) diacetate, chlorhexidine digluconate or chlorhexidine dihydrochloride, is effectual to
Gram-negative bacteria and is superior to the compound of the formula II in disinfecting Gram-positive and fungi.
In accordance with the present invention, the germicidal composition is prepared by combining the diiodomethyl-p-tolyl sulfone of the formula I with the 5-amino-1,3-bis(2 ethylhexyl)-5-methyl-hexahydropyrimidine of formula II and/or the compound of the formula III, whereby the composition can disinfect Gram-positive and Gram-negative bacteria as well as the eucaryotes such as yeasts and fungi.
For example, the composition according to the present invention is effective to bacteria such as Bacillus subtilis, Escherichiacoli, Klebsiella pneumonia, Micrococcus multicida, Mycobacterium tuberculosis, Proteus vulgaris, Shieqella dvsenteria, Staohvlococcus aureus, Staphylococcus epidermis,
Streptococcus faecalis and the like. The inventive germicidal composition inhibits the growth of yeasts or fungi, such as Aspergillus sp., Aerobacidium pullulans, Candida sp., EDidermoohyton sp., Fusarium sp., MicrosDorum sp., Malassezia furfur, Penicillium citrinum, TrichoDhvton sp., and like.
The composition ratio of the ingredients is preferably on the order of 1:1 weight ratio in case that the germicidal composition comprises of the compounds of the formulas I and
II or the compounds of the formulas I and III. In the meanwhile, the composition ratio is preferably on the order of 1:1:1 weight ratio in case that the germicidal composition comprised of all the compounds of the formulas I, II and III.
Preferred solvent to be used in the present invention is alcohols and more preferably ethanol.
According to the present invention, the germicidal composition may be changed into a useful form including various other materials. For example, the inventive germicidal composition may be admixed with soap base in order to manufacture a soap as described later. The germicidal composition according to the present invention may be also added into an organic solvent such as ethanol in order to prepare an effectual sterilizing solution for surgery. The germicidal composition and the soap including the same have an admirable effect in inhibiting the growth of microorganisms, so that may be utilized for cleaning or sterilizing hard parts of household goods, such as wall, floor, table, article of plastics and the like, or for laundering clothes to sterilize them.
Particularly, the germicidal composition and the germicidal soap according to the present invention have a remarkable disinfecting power to yeasts and antrophylic fungi which are strongly penetrative into human body, such as
Candida albicans, TrichoDhvton mentaqroDhvtes, and Eoidermophyton floccosum. These exemplary microorganisms cause fungus-type skin diseases such as eczematosis, dermatophytosis, trichophytia and the like.
EXAMPLE 1
Preparation of Germicidal Composition.
First, 20 g of diiodomethyl-p-tolyl sulfone was dissolved in 1,980 ml of 99 % pure ethanol. Into the solution, 20 g of 5-amino-1 13-bis(2-ethylhexyl )-5-methyl-hexahydropyrimidine and 20 g of chlorhexidine digluconate were added, and were stirred vigorously for 5 minutes to prepare a germicidal composition.
The prepared composition contained the three effective ingredients of 20,000 ppm, respectively.
It is apparent that the concentration of the effective ingredients and the ratio thereof may vary in dependence with the purpose intended.
EXAMPLE 2
The growth inhibitory effects of the composition prepared in the Example 1 were measured for a variety of microorganisms. Herein, the growth inhibitory effect was said to be the value of minimal inhibitory concentration (hereinafter "MIC-') ) of germicidal composition, which was determined by inoculating the definite number of microorganisms in suitable culture media containing various concentrations of the germicidal compositions, respectively, culturing the microorganisms at a constant temperature for a time and selecting the medium with a minimal concentration of the composition in which the microorganisms was not able to grow.
The culture composition for the growth of microorganisms was as shown in the following Tables 1 and 2.
Table 1
Medium for the growth of Bacteria.
Yeast Extract 3 g
Trypton 5 9 Glucose 1 g
Distilled Water 1 l (pH 5.6)
Table 2
Medium for the growth of Fungi.
Malt Extract 40 g
Peptone 10 g
Chloramphenicol 10 mg
Distilled Water 1 l (pH 5.6) * when preparing a plate culture, agar was added in
an amount of 1.5 %
The medium components were sterilized at 121 etc for 15 minutes according to a conventional method to be used.
A stock solution for the microorganisms was prepared as follows: plate cultures were seeded by picking up a minute quantity of bacteria and yeasts cells on a platinum needle, previously sterilized by passing through a flame, and drawing it several times rapidly and lightly across the surfaces of the cultures according to the conventional streaking method; the microorganisms were cultured at 30 C for 2 to 3 days to develop into isolated colonies; the microorganism cells on the isolated colonies were picked up on a loop and were suspended in 0.9 % NaCl solution (hereinafter, physiological saline solution"). In case of fungi1 they were incubated on a plate culture at 30 C for 5 to 7 days to form spores.Into the plate cu culture, 10 ml of a physiological saline solution containing about 5 X by weight of Tween 80 was poured and then a spore suspension was prepared by scraping the culture surface with the loop.
The stock solution thus prepared was measured to count the total number of microorganisms included therein, in a conventional manner and then, was inoculated in liquid cultures containing various concentrations of the germicidal compositions, respectively. The size of inoculum had to be maintained 104 cfu/ml. After inoculating, the culture vessel was rotated in a speed of 150 rpm at 30 C. After 48 hours for bacteria1 or 72 hours for fungi, the growth was investigated to determine MICs.
The results of the germicidal composition of Example 1 for each groups of microorganisms are given as shown in the following table 3.
EXAMPLE 3
The sterilizing effects of the germicidal composition prepared in Example 1 were measured for various microorganisms. Herein, the sterilizing effect was said to be the value of minimal biocidal concentration (hereinafter "MBC") of the germicidal composition, which was determined by inoculating the definite number of microorganisms in suitable culture media containing various concentrations of the germicidal compositions, respectively, incubating the microorganisms for some time and selecting the medium with a minimal concentration of the composition in which the number of the cultured microorganisms became less than 0.1 % of that in the inoculum.In the conventional total viable cell count method, the value was determined by performing the experiment of Example 2 and measuring the number of residual microorganisms which were survived in culture media wherein microorganisms were unable to grow.
The results of the germicidal composition of Example 1 for each group of microorganisms are given as shown in the following Table 3.
Table 3
MIC and MBC of the germicidal composition for microorganisms.
Microorganisms MIC(ppm) MBC(ppm)
- Bacteria
Bacillus subtilis 50 50
Escherichia coli 100 200
Mycobacterium tuberculosis 250 500
Staphylococcus aureus 200 300
Streptococcus faecalis 200 300 Yeasts Candida albicans 100 200
- Fungi
Aspergillus sp. 38 75.
Epidermophyton sp. 38 75
Trichophyton sp. 38 75
EXAMPLE 4
Manufacture of germicidal soap
It is important to know the dilution degree of each constituents consisting of the soap when the soap is used, since the concentrations of each constituents are to be determined In order to manufacture a soap. Herein, there was referred a method which was disclosed in Eurdpean Patent No.
0 363 215 (A2), which analyzed the influence of constituents into the properties of the soap. That is, it was assumed that the constituents of soap was diluted 100 times when the soap was used.
The germicidal composition of Example 1 was added in a concentration of not less than 25 X to manufacture a soap which had a potent sterilizing power to all microorganisms shown in the above Table 3.
The composition of soap was as follows:
- Soap base or Neat soap 97.5 9
- The germicidal composition 25.0 ml
- Other additives
Perfume 1.5 ml
Pigment 0.01 g
The soap base was subjected to the treatment of milling for 5 minutes to pulverize it completely. With stirring the pulverized, the germicidal composition and the other additives were added. The resulting mixture was dried to vaporize ethanol completely and to make the water content less than 5 %. The dried mixture was again subjected to milling for 15 minutes to mix the added constituents completely. Maintaining the temperature in 32 to 37 C, the mixture was plodded in a
Stephen Beck plodder, followed by the injection of a form of ribbon. Using a midget multi press, the injected mixture was pressed to form a suitable shape of soap.
On manufacturing a germicidal soap, each effective ingredient may be incorporated in a concentration of 0.5 X, based on the weight of soap base, instead of using the ethanol solution containing the effective ingredients.
EXAMPLE 5
The growth inhibitory effects of the germicidal soap manufactured in Example 4 were measured for various microorganisms. Herein, the growth inhibitory effect is represented by growth inhibitory degree (%) which means a relative extent in that the aqueous solution of soap containing the germicidal composition inhibits the growth of microorganism, as compared with the aqueous solution of soap without the germicidal composition.
The growth inhibitory effect was determined as follows: 0.5 ml of stock solution containing various microorganisms in the quantity of 1,000 cfu/ml was admixed with 2 % soap solution (a suspension containing 2 g of soap and 100 ml of sterilized, distilled water) and then, the resulting solution was poured into a plate culture and was incubated at 30 'C for 48 hours for bacteria or for 72 hours for yeasts and fungi to develop into colonies. The numbers of colonies on the culture were counted to compare the treatment with the soap containing the germicidal composition with the soap without the germicidal composition.
The results are given as shown in Table 4.
Table 4
Growth inhibitory effect of germicidal soap for microorganisms
Staphylococcus aureus Candida albicans richophyton sp.
survival no IR* survival no IR survival no IR soap (cfu) (%) (cfu) (X) (cfu) (x) A 1200 - 760 - 1,070 B 0 100 4 99 0 100 Growth Inhibitory rate A: A: not including the germicidal ingredients B: prepared according to Example 4
EXAMPLE 6
The sterilizing effects of the soap manufactured in
Example 4 were measured for various microorganisms. Herein, the sterilizing effect is represented by sterilizing rate (%) which means a relative extent in that the aqueous solution of soap containing the germicidal composition inhibits the growth of microorganism, as compared with the aqueous solution of soap without the germicidal composition.
The sterilizing effects were determined as follows: 0.5 ml of stock solution containing various microorganisms in the quantity of 1,000 cfu/ml"was admixed with 0.5 ml of 2 % soap solution (a suspension containing 2 g of soap and 100 ml of sterilized, distilled water) in a microcentrifuge tube and left at 30 'C for 10 minutes; microorganisms were inoculated to the soap solution and then, centrifuged at a speed of 8,000 rpm for 5 minutes; the supernatantwas removed carefully; 1 ml of physiological saline solution was poured into the residual precipitated microorganisms to wash the soap solution; the last step was repeated 2 to 3 times and then 1 ml of physiological saline solution was poured into the residual precipitated microorganisms; the resulting solution was poured in a plate culture, which was subsequently incubated at 30 C for 48 hours for bacteria and for 72 hours for yeasts and fungi. The numbers of colonies on each culture were counted to compare the treatment with the soap containing the germicidal composition with the soap without the germicidal composition.
The results are given as shown in Table 5.
Table 5
Sterilizing effect of germicidal soap for microorganisms
Staphylococcus aureus Candida albicans Trichophyton sp.
survival no Sir* survival no SR survival no SR soap (cfu) (X) (cfu) (X) (cfu) (X) A 700 - 825 - 730 B 7 99 8 99 204 72 Sterilizing rate A: A: not including the germicidal ingredients + B: prepared according to Example 4
As apparent from the above examples, it is expected that the germicidal composition and the soap containing the same according to the present invention are capable of preventing the skin from being infected by harmful microorganisms as well as curing the previously infected regions.
Whilst the present invention has been described with reference to certain preferred embodiments and examples, it will be appreciated by those skilled in the art that numerous variations and modifications are possible without departing from the spirit or scope of the invention as broadly described.
Claims (7)
1. A germicidal composition, which comprises of: a compound represented by the following formula I;
at least one or both of the compounds represented by the following formulas II and III
wherein R is selected from the group consisting of di acetate, digluconate and di hydrochloride; and
a solvent capable of dissolving said compounds.
2. A germicidal composition according to Claim 1, in which said solvent is alcohol.
3. A germicidal composition according to Claim 1, in which said compound of formula I and said compound of formula
II or III are added in a weight ratio of 1:1, or said compound of formulas I, II and III are added in a weight ratio of 1:1:1.
4. A germicidal soap, comprising a composition which comprises of: a compound represented by the following formula
I; and
at least one or both of compounds represented by the following formulas II and III
wherein R is selected from the group consisting of diacetate, digluconate and dihydrochloride.
5. A germicidal soap according to claim 4, in which the composition is directly added to a soap base.
6. A germicidal soap according to Claim 4, in which the composition is dissolved in an alcohol to be added to a soap base.
7. A germicidal soap according to Claim 6, in which the alcohol is ethanol.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019920019277A KR960004500B1 (en) | 1992-10-20 | 1992-10-20 | Sterilization Compositions and Soaps Containing the Same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB9321537D0 GB9321537D0 (en) | 1993-12-08 |
| GB2271719A true GB2271719A (en) | 1994-04-27 |
| GB2271719B GB2271719B (en) | 1996-05-22 |
Family
ID=19341449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9321537A Expired - Fee Related GB2271719B (en) | 1992-10-20 | 1993-10-19 | Germicidal composition and soap containing the same |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH07101810A (en) |
| KR (1) | KR960004500B1 (en) |
| CN (1) | CN1096921A (en) |
| BR (1) | BR9304037A (en) |
| FR (1) | FR2696903B1 (en) |
| GB (1) | GB2271719B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5829442A (en) * | 1996-06-12 | 1998-11-03 | Medical Concepts Development, Inc. | Antimicrobial containing solventless hot melt adhesive composition |
| FR2822070A1 (en) * | 2001-03-15 | 2002-09-20 | Andre Salkin | Treatment of adolescence associated skin disorders, e.g. acne or inflammatory lesions, using cosmetic or pharmaceutical composition containing low concentrations of biguanide and pyrimidine compounds |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0606877A2 (en) * | 2005-01-28 | 2009-07-21 | Procter & Gamble | diiodomethyl p-tolyl sulfone as a particulate dispersion in a liquid solvent |
| CN101336637B (en) * | 2008-08-27 | 2011-12-07 | 广州中大药物开发有限公司 | Complex type broad-spectrum disinfectant and use thereof |
| CN114097815A (en) * | 2021-11-25 | 2022-03-01 | 兰州大学 | Application of medical compound with amidine skeleton in resisting plant pathogenic bacteria |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59163474A (en) * | 1983-03-04 | 1984-09-14 | 旭化成株式会社 | Method for manufacturing polyamide fiber products with antibacterial properties |
| JPS59179877A (en) * | 1983-03-31 | 1984-10-12 | 旭化成株式会社 | Production of anti-bacterial polymer fiber having vinyl or vinylidene group |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185120A (en) * | 1978-10-02 | 1980-01-22 | Abbott Laboratories | Topical treatment of fungal or yeast infections using p-tolyl diiodomethyl sulfone |
| US4326977A (en) * | 1980-11-10 | 1982-04-27 | Basf Wyandotte Corporation | Liquid antiseptic cleaners with improved foaming properties |
| FR2552305B1 (en) * | 1983-09-22 | 1985-12-20 | Salkin Andre | HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE |
| GB8907298D0 (en) * | 1989-03-31 | 1989-05-17 | Ici Plc | Composition and use |
| GB9024133D0 (en) * | 1990-11-06 | 1990-12-19 | Ici Plc | Aqueous composition |
-
1992
- 1992-10-20 KR KR1019920019277A patent/KR960004500B1/en not_active Expired - Fee Related
-
1993
- 1993-10-19 GB GB9321537A patent/GB2271719B/en not_active Expired - Fee Related
- 1993-10-20 JP JP5286062A patent/JPH07101810A/en active Pending
- 1993-10-20 BR BR9304037A patent/BR9304037A/en not_active Application Discontinuation
- 1993-10-20 FR FR9312498A patent/FR2696903B1/en not_active Expired - Fee Related
- 1993-10-20 CN CN93120240A patent/CN1096921A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59163474A (en) * | 1983-03-04 | 1984-09-14 | 旭化成株式会社 | Method for manufacturing polyamide fiber products with antibacterial properties |
| JPS59179877A (en) * | 1983-03-31 | 1984-10-12 | 旭化成株式会社 | Production of anti-bacterial polymer fiber having vinyl or vinylidene group |
Non-Patent Citations (2)
| Title |
|---|
| WPI Abstract Accession No. 84-266835/43 & JP 59163474 A * |
| WPI Abstract Accession No. 84-291650/47 & JP 59179877 A * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5829442A (en) * | 1996-06-12 | 1998-11-03 | Medical Concepts Development, Inc. | Antimicrobial containing solventless hot melt adhesive composition |
| US6607746B2 (en) | 1996-06-12 | 2003-08-19 | Medical Concepts Development, Inc. | Antimicrobial containing solventless hot melt adhesive composition |
| FR2822070A1 (en) * | 2001-03-15 | 2002-09-20 | Andre Salkin | Treatment of adolescence associated skin disorders, e.g. acne or inflammatory lesions, using cosmetic or pharmaceutical composition containing low concentrations of biguanide and pyrimidine compounds |
| EP1247521A1 (en) * | 2001-03-15 | 2002-10-09 | André Salkin | Use of biguanide and pyrimidine derivatives for the preparation of a topical skin care composition |
Also Published As
| Publication number | Publication date |
|---|---|
| KR960004500B1 (en) | 1996-04-06 |
| KR940008673A (en) | 1994-05-16 |
| BR9304037A (en) | 1994-06-07 |
| GB2271719B (en) | 1996-05-22 |
| FR2696903A1 (en) | 1994-04-22 |
| CN1096921A (en) | 1995-01-04 |
| JPH07101810A (en) | 1995-04-18 |
| FR2696903B1 (en) | 1995-11-03 |
| GB9321537D0 (en) | 1993-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7026353B2 (en) | Inhibition of Gram positive bacteria | |
| El-Shouny et al. | Antimicrobial activity of pyocyanin produced by Pseudomonas aeruginosa isolated from surgical wound-infections | |
| WO2010000744A2 (en) | Use of cationic surfactants as sporicidal agents | |
| TW201216859A (en) | Disinfectant and antiseptic formulation having reduced iodine content | |
| KR20200039847A (en) | Aqueous hypochlorous acid solution | |
| Bhat et al. | Antimicrobial activities of soap and detergents | |
| KR101506185B1 (en) | Antimicrobial compositions that inhibit the quaternary ammonium compounds-resistant bacteria | |
| KR102207512B1 (en) | Lactobacillus jensenii swpm104 which has antibacterial activity | |
| Hashem et al. | Bioactive jute fabrics for packaging and storage of grains and legumes applications | |
| GB2271719A (en) | Germicidal composition and soap | |
| Burgess et al. | Laboratory transmission of Enterobacteriaceae by the oriental cockroach, Blatta orientalis | |
| EP1481666B1 (en) | A composition for re-establishment of the vaginal ecosystem | |
| KR20030037094A (en) | Antibiotic compositions comprising plant extract | |
| KR101970656B1 (en) | Novel Streptomyces lienomycini DS620 Strain and Antimicrobial Composition Comprising Extract Thereof | |
| US4753749A (en) | Microbiocidal cleaning agent and preparation thereof | |
| KR100893065B1 (en) | Antimicrobial composition containing chlorogenic acid as an active ingredient | |
| CN113303329B (en) | Disinfectant containing o-phenylphenol, preparation method and application thereof | |
| Ma et al. | Activities and mechanisms of eugenol and cinnamaldehyde against Legionella pneumophila | |
| TW200924788A (en) | A plant essential oil composition with bacteria-killing function | |
| Isenberg | Clinical laboratory studies of disinfection with Sporicidin | |
| KR102604612B1 (en) | Hand sanitizer composition with excellent antibacterial durability | |
| KR102430080B1 (en) | Antibacterial composition comprising methyl gallate and tylosin | |
| Rege et al. | IN VITRO ANTIBACTERIAL AND ANTIBIOFILM ACTIVITIES OF ASCORBIC ACID AGAINST CLINICAL ISOLATES | |
| IL22494A (en) | Controlling the growth of micro-organisms | |
| US7157499B2 (en) | Medical application of oxidized monoterpenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19971019 |